Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RNA sequencing of Xanthobacter dioxanivorans YN2

PROVIDER: PRJNA640796 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12066361_1.fastq.gz	Fastqsanger.gz
	SRR12066361_2.fastq.gz	Fastqsanger.gz
	SRR12066362_1.fastq.gz	Fastqsanger.gz
	SRR12066362_2.fastq.gz	Fastqsanger.gz
	SRR12066363_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Xanthobacter dioxanivorans strain:YN2

Project description:Xanthobacter dioxanivorans YN2 Genome sequencing

| PRJNA523944 | ENA

Analysis of gene expression in Pseudonocardia dioxanivorans strain CB1190 during growth with dioxane, glycolate or pyruvate

Project description:Analysis of gene expression in Pseudonocardia dioxanivorans strain CB1190 during growth with dioxane, glycolate or pyruvate.

2012-02-21 | GSE33197 | GEO

Pseudonocardia dioxanivorans strain CB1190 during growth with H2/bicarbonate or pyruvate

Project description:Analysis of gene expression in Pseudonocardia dioxanivorans strain CB1190 during growth with H2/bicarbonate or pyruvate

2013-04-24 | GSE41145 | GEO

Pseudonocardia dioxanivorans strain CB1190 during growth on THF or succinate

Project description:Analysis of gene expression in Pseudonocardia dioxanivorans strain CB1190 during growth on THF (tetradhydrofuran) or succinate, and re-analysis of GSE33197 published expression data.

2013-07-12 | GSE48814 | GEO

Actinomadura luteofluorescens strain:YN2

Project description:Actinomadura luteofluorescens strain:YN2 Genome sequencing

| PRJNA1079291 | ENA

Siccibacter colletis isolate:YN2

Project description:Siccibacter colletis isolate:YN2 Genome sequencing

| PRJNA726370 | ENA

Pseudonocardia dioxanivorans CB1190

Project description:Pseudonocardia dioxanivorans CB1190 genome sequencing project

| PRJNA40557 | ENA

Identification of the molecular basis of anti-cancer effect of Huaier.

Project description:Intervention type:DRUG. Intervention1:Huaier, Dose form:GRANULES, Route of administration:ORAL, intended dose regimen:20 to 60/day by either bulk or split for 3 months to extended term if necessary. Control intervention1:None. Primary outcome(s): For mRNA libraries, focus on mRNA studies. Data analysis includes sequencing data processing and basic sequencing data quality control, prediction of new transcripts, differential expression analysis of genes. Gene Ontology (GO) and the KEGG pathway database are used for annotation and enrichment analysis of up-regulated genes and down-regulated genes. For small RNA libraries, data analysis includes sequencing data process and sequencing data process QC, small RNA distribution across the genome, rRNA, tRNA, alignment with snRNA and snoRNA, construction of known miRNA expression pattern, prediction New miRNA and Study of their secondary structure Based on the expression pattern of miRNA, we perform not only GO / KEGG annotation and enrichment, but also different expression analysis.. Timepoint:RNA sequencing of 240 blood samples of 80 cases and its analysis, scheduled from June 30, 2022..

| 2612481 | ecrin-mdr-crc

Ligilactobacillus faecis strain:YN2-84

Project description:Ligilactobacillus faecis strain:YN2-84 Genome sequencing

| PRJNA771777 | ENA

Enterococcus faecium strain:YN2-1

Project description:Enterococcus faecium strain:YN2-1 Genome sequencing

| PRJNA528410 | ENA